219 related articles for article (PubMed ID: 9693251)
1. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
Amark P; Bussman G; Eksborg S
Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
[TBL] [Abstract][Full Text] [Related]
2. Dosage escalation of intravesical oxybutynin in the treatment of neurogenic bladder patients.
Haferkamp A; Staehler G; Gerner HJ; Dörsam J
Spinal Cord; 2000 Apr; 38(4):250-4. PubMed ID: 10822396
[TBL] [Abstract][Full Text] [Related]
3. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
Greenfield SP; Fera M
J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
[TBL] [Abstract][Full Text] [Related]
4. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
Von Zweigbergk M; Nordin B; Jonsson S
Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
[No Abstract] [Full Text] [Related]
5. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder.
Amark P; Eksborg S; Juneskans O; Bussman G; Palm C
Br J Urol; 1998 Dec; 82(6):859-64. PubMed ID: 9883225
[TBL] [Abstract][Full Text] [Related]
7. Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients.
Connor JP; Betrus G; Fleming P; Perlmutter AD; Reitelman C
J Urol; 1994 Apr; 151(4):1045-7. PubMed ID: 8126787
[TBL] [Abstract][Full Text] [Related]
8. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.
Ferrara P; D'Aleo CM; Tarquini E; Salvatore S; Salvaggio E
BJU Int; 2001 May; 87(7):674-8. PubMed ID: 11350411
[TBL] [Abstract][Full Text] [Related]
9. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction.
Vaidyananthan S; Soni BM; Brown E; Sett P; Krishnan KR; Bingley J; Markey S
Spinal Cord; 1998 Jun; 36(6):409-14. PubMed ID: 9648197
[TBL] [Abstract][Full Text] [Related]
10. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
[TBL] [Abstract][Full Text] [Related]
11. Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder.
Kaplinsky R; Greenfield S; Wan J; Fera M
J Urol; 1996 Aug; 156(2 Pt 2):753-6. PubMed ID: 8683776
[TBL] [Abstract][Full Text] [Related]
12. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.
Kasabian NG; Bauer SB; Dyro FM; Colodny AH; Mandell J; Retik AB
Am J Dis Child; 1992 Jul; 146(7):840-3. PubMed ID: 1496955
[TBL] [Abstract][Full Text] [Related]
13. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
[TBL] [Abstract][Full Text] [Related]
14. Intravesical therapy for the treatment of neurogenic bladder in children.
Holland AJ; King PA; Chauvel PJ; O'Neill MK; McKnight DL; Barker AP
Aust N Z J Surg; 1997 Oct; 67(10):731-3. PubMed ID: 9322726
[TBL] [Abstract][Full Text] [Related]
15. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
Lehtoranta K; Tainio H; Lukkari-Lax E; Hakonen T; Tammela TL
Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352
[TBL] [Abstract][Full Text] [Related]
17. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
[TBL] [Abstract][Full Text] [Related]
18. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity.
Prasad KV; Vaidyanathan S
Br J Urol; 1993 Nov; 72(5 Pt 2):719-22. PubMed ID: 8281402
[TBL] [Abstract][Full Text] [Related]
19. Intravesical oxybutynin for spinal cord injury patients.
Szollar SM; Lee SM
Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy.
Buyse G; Verpoorten C; Vereecken R; Casaer P
Eur J Pediatr Surg; 1995 Dec; 5 Suppl 1():31-4. PubMed ID: 8770576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
